Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 27

Sort by

Sort Order Select

Journal Articles

Real-World Experience of Switching to Prophylactic Efanesoctocog Alfa in Patients with Moderate and Severe Hemophilia a: An Analysis of the Adelphi Hemophilia Wave III Disease Specific Programme

Maissaa Janbain, Miguel A. Escobar, Manuel Carcao, Andrew Wilson, Jennifer Dumont, Nathan Ball, Ella Morton, Duygu Bozkaya, Anne-Laure Tardy, Sylvie Bozzi

Blood (2024) 144 (Supplement 1): 131.

https://doi.org/10.1182/blood-2024-193764

Published: 2024

Journal Articles

Cost Comparison of Efanesoctocog Alfa with Existing Factor VIII Replacement Therapies for Major Surgeries in People with Severe Hemophilia a

Janice Staber, Alix Arnaud, Ion Agirrezabal, Lane Anson, Andrew Wilson, Nana Kragh, Doris V. Quon, Allison P Wheeler

Blood (2024) 144 (Supplement 1): 2582.

https://doi.org/10.1182/blood-2024-207568

Published: 2024

Journal Articles

Real-World Unmet Needs in Patients with Hemophilia A without Inhibitors in the US: Results from the PicnicHealth Database

Courtney Thornburg, Allison P Wheeler, Sylvie Bozzi, Gandarvaka Miles, Kalyani Hawaldar, Andrew Wilson, Gillian Hanson, Noelle Liao, Amanda Wilson

Blood (2023) 142 (Supplement 1): 2380.

https://doi.org/10.1182/blood-2023-181655

Published: 2023

Journal Articles

Phase I Study Evaluating Outcomes of Autologous HIV-Specific T Cells Targeting Non-Escaped Epitopes (HST-NEET) Therapy in HIV+ Individuals on ART (NCT03485963)

Danielle K. Sohai, Michael Keller, Patrick J. Hanley, Anushree Datar, Emily Reynolds, Dennis Copertino, Chase McCann, Haili Lang, Cecilia Motta, Andrew Wilson, Rebecca Lynch, Winiffer Conce Alberto, Zabrina L. Brumme, Natalie N. Kinloch, Conrad Russell Y. Cruz, Lynsay MacLaren Ehui, Sarah Henn, R. Brad Jones, Catherine M Bollard

Blood (2022) 140 (Supplement 1): 7498–7499.

https://doi.org/10.1182/blood-2022-165775

Published: 2022

Journal Articles

A Retrospective Audit of the Use of Next-Generation Sequencing in the Management of Myelofibrosis Patients in North London Hospitals

Ke Xu, MD MRCP, FRCPath, Andrew Wilson, MA, MSc, PhD MRCP, FRCPath, Elisabeth P. Nacheva, MD PhD FRCPath, Temenuzhka Boneva, MD PhD, Rajeev Gupta, MB.ChB, PhD FRCP, FRCPath

Blood (2020) 136 (Supplement 1): 14.

https://doi.org/10.1182/blood-2020-133779

Published: 2020

Journal Articles

Overexpression of BCL-2 Does Not Inhibit Autophagy in Human Follicular and Diffuse Large B-Cell Lymphomas

Aine McCarthy, PhD, Andrew James Clear, BSc, Jacek Marzec, Rita Coutinho, MD, Robert D. Petty, PhD, Janet Matthews, Andrew Wilson, Sameena Iqbal, Maria Calaminici, MD PhD, John G. Gribben, MD DSc, Li Jia, PhD MD

Blood (2014) 124 (21): 3007.

https://doi.org/10.1182/blood.V124.21.3007.3007

Published: 2014

Journal Articles

Deletion of Fanca or Fancd2 dysregulates Treg in mice

Wei Du, Ozlem Erden, Andrew Wilson, Jared M. Sipple, Jonathan Schick, Parinda Mehta, Kasiani C. Myers, Kris A. Steinbrecher, Stella M. Davies, Qishen Pang

Blood (2014) 123 (12): 1938–1947.

https://doi.org/10.1182/blood-2013-09-528018

Published: 2014

Includes: Supplemental data

Journal Articles

Deletion Of Fanca Or Fancd2 Dysregulates Treg Activity and Exacerbates Gvhd In Mice

Wei Du, MD, PhD, Ozlem Erden, MS, Andrew Wilson, MS, Jared Sipple, Jonathan Schick, Parinda A. Mehta, Stella M. Davies, MBBS, PhD, Kris Steinbrecher, PhD, Qishen Pang, Ph.D

Blood (2013) 122 (21): 3239.

https://doi.org/10.1182/blood.V122.21.3239.3239

Published: 2013

Journal Articles

Fancd2 Deficiency Impairs Autophagy Via Deregulating The Ampk/Foxo3a/Akt Pathway

Mathieu Sertorio, Ph.D, Surya Amarachintha, Ph.D, Andrew Wilson, BS, Qishen Pang, Ph.D

Blood (2013) 122 (21): 3713.

https://doi.org/10.1182/blood.V122.21.3713.3713

Published: 2013

Journal Articles

Hemopoietic Stem Cells In Polycythemia Vera and Essential Thrombocythemia Have Increased TNF-Alpha That Decreases After Pegylated Interferon-a Therapy, But Not Hydroxyurea, and Correlates With Suppression Of PV and ET Clones

Sabina Swierczek, PhD, Mohamed E Salama, MD, Katherine King, MD, PhD, Andrew Wilson, PhD, Sheryl Tripp, MD, Sherrie L. Perkins, MD, PhD, Margaret A. Goodell, PhD, Josef T. Prchal, MD

Blood (2013) 122 (21): 2827.

https://doi.org/10.1182/blood.V122.21.2827.2827

Published: 2013

Journal Articles

Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma

David Wrench, MD, PhD, Hasan Rizvi, MD, Andrew Wilson, Ciaran O'Riain, MD, PhD, Andrew Clear, Janet Matthews, Daniele Laszlo, MD, T. Andrew Lister, MD, John G. Gribben, MD, DSc, FRCP, FMedSci, FRCPath, Maria Calaminici, MD, PhD, Silvia Montoto, MD

Blood (2013) 122 (21): 4260.

https://doi.org/10.1182/blood.V122.21.4260.4260

Published: 2013

Journal Articles

Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells

Paul Greaves, Andrew Clear, Andrew Owen, Sameena Iqbal, Abigail Lee, Janet Matthews, Andrew Wilson, Maria Calaminici, John G. Gribben

Blood (2013) 122 (16): 2856–2863.

https://doi.org/10.1182/blood-2013-06-508044

Published: 2013

Includes: Supplemental data

Journal Articles

The Clinical Course of Patients with Follicular Lymphoma in the Rituximab Era: A Paradigm Shift

Inas El-Najjar, MBBCH, Janet Matthews, Andrew Wilson, John G Gribben, Silvia Montoto, MD

Blood (2012) 120 (21): 1580.

https://doi.org/10.1182/blood.V120.21.1580.1580

Published: 2012

Journal Articles

Prospective Evaluation of a TTP Prediction Score in an Independent Cohort

Melissa J. Bentley, M.D., Andrew Wilson, George M Rodgers, MD, PhD

Blood (2012) 120 (21): 1093.

https://doi.org/10.1182/blood.V120.21.1093.1093

Published: 2012

Journal Articles

Methylation of AR locus does not always reflect X chromosome inactivation state

Sabina I. Swierczek, Lucie Piterkova, Jaroslav Jelinek, Neeraj Agarwal, Sue Hammoud, Andrew Wilson, Kimberly Hickman, Charles J. Parker, Bradley R. Cairns, Josef T. Prchal

Blood (2012) 119 (13): e100–e109.

https://doi.org/10.1182/blood-2011-11-390351

Published: 2012

Includes: Supplemental data

Journal Articles

The PD1/PD-L1 Axis in the Classical Hodgkin Lymphoma Microenvironment: PD-1 Is Rarely Expressed but Identifies Patients with High-Risk Disease

Paul Greaves, Andrew James Clear, BSc, Andrew Owen, Andrew Wilson, Janet Matthews, Maria Calaminici, MD, John G. Gribben, MD, DSc

Blood (2011) 118 (21): 1560.

https://doi.org/10.1182/blood.V118.21.1560.1560

Published: 2011

Journal Articles

HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era,

Silvia Montoto, MD, Kate Shaw, Jessica Okosun, Shreyans Gandhi, Paul Fields, MD, PhD, Andrew Wilson, Milensu Shanyinde, Kate Cwynarski, Robert E. Marcus, MBBS, FRCP, FRCPath, Johannes de Vos, Anna Marie Young, Melinda Tenant-Flowers, FRCP MSc, Chloe Orkin, Margaret Johnson, Daniella Chilton, John G. Gribben, MD, DSc, Mark Bower, MD

Blood (2011) 118 (21): 3646.

https://doi.org/10.1182/blood.V118.21.3646.3646

Published: 2011

Journal Articles

Exploring the Immune Microenvironment of Diffuse Large B Cell Lymphoma in a Tissue Microarray: Predicting Survival with a Score That Incorporates Macrophages, Cytotoxic and Regulatory T Cells

Rita Coutinho, Andrew James Clear, BSc, David Andrew Owen, Paul Greaves, Simon L. Hallam, Andrew Wilson, Janet Matthews, Maria Calaminici, MD, John G. Gribben, MD, DSc

Blood (2011) 118 (21): 951.

https://doi.org/10.1182/blood.V118.21.951.951

Published: 2011

Journal Articles

An Immunohistochemical Score Based On CD68 and FOXP3 Expression In the Tumour Microenvironment at Diagnosis Defines Prognostic Groups In Both Early and Advanced Stage Classical Hodgkin Lymphoma

Paul Greaves, Andrew James Clear, BSc, David Andrew Owen, Finlay Macdougall, Andrew Wilson, Andrew Lister, MD, Maria Calaminici, John G. Gribben, MD, DSc

Blood (2010) 116 (21): 750.

https://doi.org/10.1182/blood.V116.21.750.750

Published: 2010

Journal Articles

Prospective Use of a Triple FISH Probe to Predict sMDS/AML Following High Dose Therapy with Autologous Stem Cell Rescue for Lymphoma.

Paul Greaves, Silvia Montoto, MD, Janet Matthews, Andrew Wilson, Daniel L P Brown, Debra Lillington, John G. Gribben, MD, DSc, Andrew Lister, MD

Blood (2010) 116 (21): 3459.

https://doi.org/10.1182/blood.V116.21.3459.3459

Published: 2010

NARROW

Real-World Experience of Switching to Prophylactic Efanesoctocog Alfa in Patients with Moderate and Severe Hemophilia a: An Analysis of the Adelphi Hemophilia Wave III Disease Specific Programme

Cost Comparison of Efanesoctocog Alfa with Existing Factor VIII Replacement Therapies for Major Surgeries in People with Severe Hemophilia a

Real-World Unmet Needs in Patients with Hemophilia A without Inhibitors in the US: Results from the PicnicHealth Database

Phase I Study Evaluating Outcomes of Autologous HIV-Specific T Cells Targeting Non-Escaped Epitopes (HST-NEET) Therapy in HIV+ Individuals on ART (NCT03485963)

A Retrospective Audit of the Use of Next-Generation Sequencing in the Management of Myelofibrosis Patients in North London Hospitals

Overexpression of BCL-2 Does Not Inhibit Autophagy in Human Follicular and Diffuse Large B-Cell Lymphomas

Deletion of Fanca or Fancd2 dysregulates Treg in mice

Deletion Of Fanca Or Fancd2 Dysregulates Treg Activity and Exacerbates Gvhd In Mice

Fancd2 Deficiency Impairs Autophagy Via Deregulating The Ampk/Foxo3a/Akt Pathway

Hemopoietic Stem Cells In Polycythemia Vera and Essential Thrombocythemia Have Increased TNF-Alpha That Decreases After Pegylated Interferon-a Therapy, But Not Hydroxyurea, and Correlates With Suppression Of PV and ET Clones

Concurrent Follicular Lymphoma At Diagnosis Has a Negative Impact On The Outcome Of Patients With Diffuse Large B Cell Lymphoma

Defining characteristics of classical Hodgkin lymphoma microenvironment T-helper cells

The Clinical Course of Patients with Follicular Lymphoma in the Rituximab Era: A Paradigm Shift

Prospective Evaluation of a TTP Prediction Score in an Independent Cohort

Methylation of AR locus does not always reflect X chromosome inactivation state

The PD1/PD-L1 Axis in the Classical Hodgkin Lymphoma Microenvironment: PD-1 Is Rarely Expressed but Identifies Patients with High-Risk Disease

HIV Status Does Not Impact on Outcome in Patients with Hodgkin Lymphoma Treated with ABVD Chemotherapy in the HAART Era,

Exploring the Immune Microenvironment of Diffuse Large B Cell Lymphoma in a Tissue Microarray: Predicting Survival with a Score That Incorporates Macrophages, Cytotoxic and Regulatory T Cells

An Immunohistochemical Score Based On CD68 and FOXP3 Expression In the Tumour Microenvironment at Diagnosis Defines Prognostic Groups In Both Early and Advanced Stage Classical Hodgkin Lymphoma

Prospective Use of a Triple FISH Probe to Predict sMDS/AML Following High Dose Therapy with Autologous Stem Cell Rescue for Lymphoma.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only